Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence. | Am J Gastroenterol;116(4): 848-849, 2021 04. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence.

Ma, Tianyi; Wu, Meng.

Ma T; 1Department of Hepatopancreatobiliary Medicine, The Second Hospital of Jilin University, Jilin, China.

Am J Gastroenterol ; 116(4): 848-849, 2021 04.

Article in English | MEDLINE | ID: covidwho-1227194

Subject(s)

COVID-19; Famotidine; Famotidine/therapeutic use; Histamine H2 Antagonists/therapeutic use; Humans; Propensity Score; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001008

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Famotidine / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2021 Document Type: Article Affiliation country: Ajg.0000000000001008